Few serum biomarker tests are applied in clinical practice and recent reports raise concerns about poor reproducibility of biomarker studies. simulations, we modelled imbalances in the number of males and females in disease and control groups. For both groups, the sex composition was varied for each simulation by 10%, with group compositions ranging from 0% to 100% males. buy AMG-Tie2-1 For each simulation, 50 samples each were selected with replacement from male (N?=?140) and female (N?=?207) discovery cohort subjects to represent the disease and control groups. A Variance in serum biomarkers with sex and female hormonal status: implications for clinical tests. Sci. Rep. 6, 26947; doi: 10.1038/srep26947 (2016). Supplementary Material Supplementary Information:Click here to view.(1.5M, pdf) Acknowledgments This work was supported by the Stanley Medical Research Institute, the European Union FP7 Rabbit polyclonal to USP20 funding plan: Marie Curie Actions Industry Academia Partnerships and Pathways (nr. 286334, PSYCH-AID project) and the NeuroBasic PharmaPhenomics project (no. 0908). J.M.R. was funded by the Edmonton Churchill Scholarship and the Cambridge Commonwealth Trust for the duration of the study. The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw, grant number 10-000-1002) and is supported by participating universities and mental health care organizations (VU University or college Medical Center, GGZ inGeest, Arkin, Leiden University or college Medical Center, GGZ Rivierduinen, University or college Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute for Quality of Healthcare (IQ healthcare), Netherlands buy AMG-Tie2-1 Institute for Health Services Research (NIVEL) and Netherlands Institute of Mental Health and Dependency (Trimbos Institute). The funders buy AMG-Tie2-1 experienced no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would also like to thank Man Chan and Mariska Bot for their helpful input into this manuscript. Footnotes Please note that SB is usually buy AMG-Tie2-1 a director of Psynova Neurotech Ltd. JDC and SB were consultants for Myriad-RBM until June 2014. The other authors declare no competing financial interests. Author Contributions J.M.R. conceived the study, analyzed and interpreted the data, and wrote the article. J.D.C. and S.B. interpreted the data and revised the article. B.W.J.H.P. acquired the data and revised the article..
